phentermine | Evidence search

Controlled drugs and drug dependence | Medicines guidance

Source: British National Formulary - BNF - 29 January 2019

Schedule 2), buprenorphine, mazindol, meprobamate, midazolam, pentazocine, phentermine, temazepam, and tramadol hydrochloride. They are...

More: Prescribing and Technical Information

Controlled drugs and drug dependence | Medicines guidance

Source: British National Formulary for Children - BNFc - 29 January 2019

Schedule 2), buprenorphine, mazindol, meprobamate, midazolam, pentazocine, phentermine, temazepam, and tramadol hydrochloride. They are...

More: Prescribing and Technical Information

Care of women with obesity in pregnancy: green-top guideline no 72

22 November 2018 - Publisher: British Journal of Obstetrics and Gynaecology

Obesity is one of the most common health risk factors in pregnancy (latest figures show 22% of pregnant women in England are obese). This guidance includes recommendations on how to manage weight...

UKMi comment

- More: Guidance

ACR-ACNM Practice Parameter for the Performance of Dopamine (DaT) Transporter Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders [PDF]

Source: American College of Radiology - 18 December 2017

d-amphetamine, methamphetamine, methylphenidate : CNS stimulants: ephedrine, phentermine Drugs that do not increase or decrease striatal...

More: Guidance

Obesity

Source: Clinical Knowledge Summaries - 01 December 2017

naltrexone-bupropion, and phentermine-topiramate) were all associated with achieving at least 5% weight loss at 52 weeks. Liraglutide...

More: Guidance

Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials

07 November 2017 - Publisher: JAMA Internal Medicine

Review (43 studies, n=49,029) found in adults at risk for diabetes (DB), lifestyle modification (LSM) and drugs (weight loss and insulin-sensitising drugs) reduced DB incidence. Effects of drugs were...

Filter results by

Results 1 - 50 of 67 sorted by relevance / date

ACR-ACNM Practice Parameter for the Performance of Dopamine (DaT) Transporter Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders [PDF]

Drug misuse and dependence: UK guidelines on clinical management [PDF]

Pediatric obesity - assessment, treatment, and prevention: an Endocrine Society clinical practice guideline [PDF]

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary [PDF]

General practice management of type 2 diabetes 2016–18 [PDF]

The safer management of controlled drugs: Annual report 2015 [PDF]

AACE/ACE clinical practice guidelines for comprehensive medical care of patients with obesity [PDF]

ASGE position statement on endoscopic bariatric therapies in clinical practice [PDF]

American association of clinical endocrinologists and American college of endocrinology : clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015 [PDF]

Smoking, nutrition, alcohol, physical activity (SNAP): a population health guide to behavioural risk factors in general practice 2nd edition [PDF]

Drug use, impaired driving and traffic accidents (2nd edition) [PDF]

American Society of Interventional Pain Physicians (ASIPP) : guidelines for responsible opioid prescribing in chronic non-cancer pain : part 2 - guidance [PDF]

Human Enhancement Drugs – The Emerging Challenges to Public Health [PDF]

Venlasov XL 75 mg and 150 mg Prolonged-release Capsules (venlafaxine hydrochloride) - PL 06464/2656-7 [PDF]

SNM practice guideline for dopamine transporter imaging with 123 I-Ioflupane SPECT 1.0 [PDF]